recombinant cholera toxin-B (NIAID)

N/A

Report date: 2025/03/20 09:43:11

Base Information

Drug Namerecombinant cholera toxin-B (NIAID)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionInterleukin-2 receptor antagonistsInterferon gamma receptor antagonists
TargetsInterferon gamma receptorInterleukin-2 receptor
Therapy Area/IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A